Top Biotechnology Companies By Revenue

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Revenue
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
RevenueEfficiencyMarket RiskExp Return
1NVO Novo Nordisk AS
290.4 B
(0.13)
 3.85 
(0.50)
2ABBV AbbVie Inc
56.33 B
 0.08 
 1.49 
 0.11 
3AMGN Amgen Inc
33.42 B
 0.10 
 1.70 
 0.16 
4GILD Gilead Sciences
28.75 B
 0.14 
 1.92 
 0.27 
5GMAB Genmab AS
21.53 B
 0.07 
 2.01 
 0.13 
6REGN Regeneron Pharmaceuticals
14.2 B
 0.03 
 3.19 
 0.08 
7VRTX Vertex Pharmaceuticals
11.02 B
(0.06)
 3.01 
(0.19)
8INCY Incyte
4.24 B
 0.20 
 2.25 
 0.45 
9JAZZ Jazz Pharmaceuticals PLC
4.07 B
 0.14 
 1.65 
 0.23 
10ONC BeiGene,
3.81 B
 0.20 
 2.36 
 0.48 
11MRNA Moderna
3.2 B
 0.08 
 3.56 
 0.29 
12UTHR United Therapeutics
2.88 B
 0.01 
 2.63 
 0.02 
13BMRN Biomarin Pharmaceutical
2.85 B
 0.05 
 1.68 
 0.08 
14BNTX BioNTech SE
2.75 B
 0.11 
 3.02 
 0.33 
15FTRE Fortrea Holdings
2.7 B
 0.07 
 6.85 
 0.47 
16RPRX Royalty Pharma Plc
2.26 B
 0.20 
 1.30 
 0.25 
17ALNY Alnylam Pharmaceuticals
2.25 B
 0.25 
 2.88 
 0.71 
18ARGX argenx NV ADR
2.19 B
 0.08 
 2.60 
 0.20 
19EXEL Exelixis
2.17 B
 0.03 
 4.01 
 0.11 
20SRPT Sarepta Therapeutics
1.9 B
(0.09)
 8.82 
(0.79)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY